Biomarkers in high grade serous ovarian cancer
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · 2024-11 · 1879 (6) · 189224
DOI: 10.1016/j.bbcan.2024.189224 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Biochimica et Biophysica Acta (BBA) - Reviews on Cancer, 2024-11. Verfasst von Mark Bates und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Histopathology, Trinity College Dublin, Dublin, Ireland; Emer Casey Molecular Pathology Research Laboratory, Coombe Women & Infants Uni…. Hauptthemen laut MEDLINE: Ovarian Neoplasms, Biomarkers, Tumor. Die Arbeit wurde bisher 24-mal zitiert (Crossref) und nennt 502 Literaturangaben.
Abstract (Originalsprache)
High-grade serous ovarian cancer (HGSC) is the most common subtype of ovarian cancer. HGSC patients typically present with advanced disease, which is often resistant to chemotherapy and recurs despite initial responses to therapy, resulting in the poor prognosis associated with this disease. There is a need to utilise biomarkers to manage the various aspects of HGSC patient care. In this review we discuss the current state of biomarkers in HGSC, focusing on the various available immunohistochemical (IHC) and blood-based biomarkers, which have been examined for their diagnostic, prognostic and theranostic potential in HGSC. These include various routine clinical IHC biomarkers such as p53, WT1, keratins, PAX8, Ki67 and p16 and clinical blood-borne markers and algorithms such as CA125, HE4, ROMA, RMI, ROCA, and others. We also discuss various components of the liquid biopsy as well as a number of novel IHC biomarkers and non-routine blood-borne biomarkers, which have been examined in various ovarian cancer studies. We also discuss the future of ovarian cancer biomarker research and highlight some of the challenges currently facing the field.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Histopathology, Trinity College Dublin, Dublin, Ireland; Emer Casey Molecular Pathology Research Laboratory, Coombe Women & Infants University Hospital, Dublin, Ireland; Trinity St James's Cancer Institute…
Zitieren
APA
Bates, M., Mohamed, B. M., Lewis, F., O'Toole, S., & O'Leary, J. J. (2024). Biomarkers in high grade serous ovarian cancer. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer, 1879(6), 189224. https://doi.org/10.1016/j.bbcan.2024.189224
Vancouver
Bates M, Mohamed BM, Lewis F, O'Toole S, O'Leary JJ. Biomarkers in high grade serous ovarian cancer. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer. 2024;1879(6):189224. doi:10.1016/j.bbcan.2024.189224
BibTeX
@article{Bates2024,
author = {Bates, Mark and Mohamed, Bashir M and Lewis, Faye and O'Toole, Sharon and O'Leary, John J},
title = {Biomarkers in high grade serous ovarian cancer},
journal = {Biochimica et Biophysica Acta (BBA) - Reviews on Cancer},
year = {2024},
volume = {1879},
number = {6},
pages = {189224},
doi = {10.1016/j.bbcan.2024.189224}
}
EUVIMED